Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach.
Caminati M, Carpagnano LF, Alberti C, Amaddeo F, Bixio R, Caldart F, De Franceschi L, Del Giglio M, Festi G, Friso S, Frulloni L, Gisondi P, Krampera M, Lippi G, Micheletto C, Piacentini G, Pinter P, Rossini M, Schiappoli M, Tecchio C, Tenero L, Tinazzi E, Senna G, Carlucci M; Multidisciplinary Group on rare dysimmune conditions with hyper-Eosinophilia (GEos). Caminati M, et al. Among authors: lippi g. World Allergy Organ J. 2024 Jul 25;17(8):100928. doi: 10.1016/j.waojou.2024.100928. eCollection 2024 Aug. World Allergy Organ J. 2024. PMID: 39156600 Free PMC article. Review.
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.
Mazzaferri F, Mirandola M, Savoldi A, De Nardo P, Morra M, Tebon M, Armellini M, De Luca G, Calandrino L, Sasset L, D'Elia D, Sozio E, Danese E, Gibellini D, Monne I, Scroccaro G, Magrini N, Cattelan A, Tascini C; MANTICO Working Group; Tacconelli E. Mazzaferri F, et al. Elife. 2022 Nov 22;11:e79639. doi: 10.7554/eLife.79639. Elife. 2022. PMID: 36413383 Free PMC article. Clinical Trial.
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients.
Bonifacio M, Montemezzi R, Parisi A, De Matteis G, Bertorelle R, Scaffidi L, Candiotto C, Lippi G, Zamò A, Chilosi M, Pizzolo G, Scarpa A, Krampera M. Bonifacio M, et al. Among authors: lippi g. Ann Hematol. 2019 Oct;98(10):2339-2346. doi: 10.1007/s00277-019-03741-8. Epub 2019 Jun 27. Ann Hematol. 2019. PMID: 31250082 Clinical Trial.
2,182 results